Prevalence of Neuroleptic-Induced Movement Disorders in Chronic Schizophrenia Inpatients
Authors:
- Matti HoliMHMatti Holi
- Katinka TuiskuKTKatinka Tuisku
- Kristian WahlbeckKWKristian Wahlbeck
- 1 January 2004
- journal article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 161 (1) , 160-163
Abstract
Since most of the world's schizophrenia patients are treated with conventional antipsychotics, the authors evaluated various methods for establishing the prevalence of neuroleptic-induced movement disorders in these patients. DSM-IV criteria and established score thresholds on a movement disorder rating scale were used to identify cases of neuroleptic-induced movement disorder in a representative Estonian patient sample of 99 chronic institutionalized schizophrenia patients, 18-65 years old, treated with conventional neuroleptics (79.8%) or clozapine (20.2%). Neuroleptic-induced movement disorders according to DSM-IV criteria were found in 61.6% of the group: 31.3% had neuroleptic-induced akathisia, 23.2% had neuroleptic-induced parkinsonism, and 32.3% had neuroleptic-induced tardive dyskinesia. Prevalence rates for akathisia and tardive dyskinesia were similar when either DSM-IV criteria or rating scale scores were used, but the prevalence rate for parkinsonism was much lower per DSM-IV criteria than according to rating scale score. Nearly two-thirds of chronic schizophrenia patients suffered from a neuroleptic-induced movement disorder. Globally, extrapyramidal adverse effects still impose a huge burden on the majority of neuroleptic-treated individuals with schizophrenia. The discrepancy between the standard identification methods for neuroleptic-induced movement disorder indicate the need for further research.Keywords
This publication has 16 references indexed in Scilit:
- Prevalence of extrapyramidal syndromes in psychiatric inpatients and the relationship of clozapine treatment to tardive dyskinesiaSchizophrenia Research, 2000
- Extrapyramidal Syndromes in Neuroleptic-Treated PatientsJournal of Clinical Psychopharmacology, 1999
- The prevalence of tardive dystonia, tardive dyskinesia, parkinsonism and akathisia The Curaçao extrapyramidal syndromes study: ISchizophrenia Research, 1996
- Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patientsAmerican Journal of Psychiatry, 1995
- The Epidemiology of Drug-induced Akathisia: Part I. Acute AkathisiaSchizophrenia Bulletin, 1995
- How to Examine Patients Using the Abnormal Involuntary Movement ScalePsychiatric Services, 1988
- Tardive DyskinesiaArchives of General Psychiatry, 1982
- Research Diagnoses for Tardive DyskinesiaArchives of General Psychiatry, 1982
- Changing epidemiology of tardive dyskinesia: an overviewAmerican Journal of Psychiatry, 1981
- A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTSActa Psychiatrica Scandinavica, 1970